Mechanism of pharmacochaperoning in a mammalian KATP channel revealed by cryo-EM

Gregory M. Martin, Min Woo Sung, Zhongying Yang, Laura M. Innes, Balamurugan Kandasamy, Larry David, Craig Yoshioka, Show-Ling Shyng

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

ATP-sensitive potassium (KATP) channels composed of a pore-forming Kir6.2 potassium channel and a regulatory ABC transporter sulfonylurea receptor 1 (SUR1) regulate insulin secretion in pancreatic β-cells to maintain glucose homeostasis. Mutations that impair channel folding or assembly prevent cell surface expression and cause congenital hyperinsulinism. Structurally diverse KATP inhibitors are known to act as pharmacochaperones to correct mutant channel expression, but the mechanism is unknown. Here, we compare cryoEM structures of a mammalian KATP channel bound to pharmacochaperones glibenclamide, repaglinide, and carbamazepine. We found all three drugs bind within a common pocket in SUR1. Further, we found the N-terminus of Kir6.2 inserted within the central cavity of the SUR1 ABC core, adjacent the drug binding pocket. The findings reveal a common mechanism by which diverse compounds stabilize the Kir6.2 N-terminus within SUR1’s ABC core, allowing it to act as a firm ‘handle’ for the assembly of metastable mutant SUR1- Kir6.2 complexes.

Original languageEnglish (US)
Article numbere46417
JournaleLife
Volume8
DOIs
StatePublished - Jul 1 2019

Fingerprint

Sulfonylurea Receptors
KATP Channels
repaglinide
Congenital Hyperinsulinism
ATP-Binding Cassette Transporters
Glyburide
Potassium Channels
Carbamazepine
Pharmaceutical Preparations
Potassium
Homeostasis
Adenosine Triphosphate
Insulin
Glucose
Mutation

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Mechanism of pharmacochaperoning in a mammalian KATP channel revealed by cryo-EM. / Martin, Gregory M.; Sung, Min Woo; Yang, Zhongying; Innes, Laura M.; Kandasamy, Balamurugan; David, Larry; Yoshioka, Craig; Shyng, Show-Ling.

In: eLife, Vol. 8, e46417, 01.07.2019.

Research output: Contribution to journalArticle

Martin, Gregory M. ; Sung, Min Woo ; Yang, Zhongying ; Innes, Laura M. ; Kandasamy, Balamurugan ; David, Larry ; Yoshioka, Craig ; Shyng, Show-Ling. / Mechanism of pharmacochaperoning in a mammalian KATP channel revealed by cryo-EM. In: eLife. 2019 ; Vol. 8.
@article{849dd48132e644ec82fffeb331b8cd6d,
title = "Mechanism of pharmacochaperoning in a mammalian KATP channel revealed by cryo-EM",
abstract = "ATP-sensitive potassium (KATP) channels composed of a pore-forming Kir6.2 potassium channel and a regulatory ABC transporter sulfonylurea receptor 1 (SUR1) regulate insulin secretion in pancreatic β-cells to maintain glucose homeostasis. Mutations that impair channel folding or assembly prevent cell surface expression and cause congenital hyperinsulinism. Structurally diverse KATP inhibitors are known to act as pharmacochaperones to correct mutant channel expression, but the mechanism is unknown. Here, we compare cryoEM structures of a mammalian KATP channel bound to pharmacochaperones glibenclamide, repaglinide, and carbamazepine. We found all three drugs bind within a common pocket in SUR1. Further, we found the N-terminus of Kir6.2 inserted within the central cavity of the SUR1 ABC core, adjacent the drug binding pocket. The findings reveal a common mechanism by which diverse compounds stabilize the Kir6.2 N-terminus within SUR1’s ABC core, allowing it to act as a firm ‘handle’ for the assembly of metastable mutant SUR1- Kir6.2 complexes.",
author = "Martin, {Gregory M.} and Sung, {Min Woo} and Zhongying Yang and Innes, {Laura M.} and Balamurugan Kandasamy and Larry David and Craig Yoshioka and Show-Ling Shyng",
year = "2019",
month = "7",
day = "1",
doi = "10.7554/eLife.46417",
language = "English (US)",
volume = "8",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications",

}

TY - JOUR

T1 - Mechanism of pharmacochaperoning in a mammalian KATP channel revealed by cryo-EM

AU - Martin, Gregory M.

AU - Sung, Min Woo

AU - Yang, Zhongying

AU - Innes, Laura M.

AU - Kandasamy, Balamurugan

AU - David, Larry

AU - Yoshioka, Craig

AU - Shyng, Show-Ling

PY - 2019/7/1

Y1 - 2019/7/1

N2 - ATP-sensitive potassium (KATP) channels composed of a pore-forming Kir6.2 potassium channel and a regulatory ABC transporter sulfonylurea receptor 1 (SUR1) regulate insulin secretion in pancreatic β-cells to maintain glucose homeostasis. Mutations that impair channel folding or assembly prevent cell surface expression and cause congenital hyperinsulinism. Structurally diverse KATP inhibitors are known to act as pharmacochaperones to correct mutant channel expression, but the mechanism is unknown. Here, we compare cryoEM structures of a mammalian KATP channel bound to pharmacochaperones glibenclamide, repaglinide, and carbamazepine. We found all three drugs bind within a common pocket in SUR1. Further, we found the N-terminus of Kir6.2 inserted within the central cavity of the SUR1 ABC core, adjacent the drug binding pocket. The findings reveal a common mechanism by which diverse compounds stabilize the Kir6.2 N-terminus within SUR1’s ABC core, allowing it to act as a firm ‘handle’ for the assembly of metastable mutant SUR1- Kir6.2 complexes.

AB - ATP-sensitive potassium (KATP) channels composed of a pore-forming Kir6.2 potassium channel and a regulatory ABC transporter sulfonylurea receptor 1 (SUR1) regulate insulin secretion in pancreatic β-cells to maintain glucose homeostasis. Mutations that impair channel folding or assembly prevent cell surface expression and cause congenital hyperinsulinism. Structurally diverse KATP inhibitors are known to act as pharmacochaperones to correct mutant channel expression, but the mechanism is unknown. Here, we compare cryoEM structures of a mammalian KATP channel bound to pharmacochaperones glibenclamide, repaglinide, and carbamazepine. We found all three drugs bind within a common pocket in SUR1. Further, we found the N-terminus of Kir6.2 inserted within the central cavity of the SUR1 ABC core, adjacent the drug binding pocket. The findings reveal a common mechanism by which diverse compounds stabilize the Kir6.2 N-terminus within SUR1’s ABC core, allowing it to act as a firm ‘handle’ for the assembly of metastable mutant SUR1- Kir6.2 complexes.

UR - http://www.scopus.com/inward/record.url?scp=85071700425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071700425&partnerID=8YFLogxK

U2 - 10.7554/eLife.46417

DO - 10.7554/eLife.46417

M3 - Article

C2 - 31343405

AN - SCOPUS:85071700425

VL - 8

JO - eLife

JF - eLife

SN - 2050-084X

M1 - e46417

ER -